Showing results (681-690 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferonsJ A Leon, M C Gutierrez, H Jiang, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Interferon gamma but not tumor necrosis factor alpha decreases susceptibility of human renal cell cancer cell lines to lymphokine-activated killer cellsY Tomita, H Watanabe, H Kobayashi, et al.Cancer Immunology, Immunotherapy : CII|September 19, 2003
T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring toolShirley M Bartido, Karen ZierCancer Immunology, Immunotherapy : CII|January 1, 1992
Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancerE J Derbyshire, R A Stahel, E J WawrzynczakCancer Immunology, Immunotherapy : CII|April 18, 2003
Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulationRadek Spisek, Gwenola Bougras, Frederic Ebstein, et al.Cancer Immunology, Immunotherapy : CII|April 18, 2003
Advancing role of radiolabeled antibodies in the therapy of cancerDavid M GoldenbergCancer Immunology, Immunotherapy : CII|June 13, 2003
Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcomeJohanna W van Sandick, Marja A Boermeester, Suzanne S Gisbertz, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumorK Roszkowski, H L Ko, W Roszkowski, et al.Cancer Immunology, Immunotherapy : CII|April 24, 2017
FKBP51s signature in peripheral blood mononuclear cells of melanoma patients as a possible predictive factor for immunotherapySimona Romano, Ester Simeone, Anna D'Angelillo, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1984
Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patientsE Yanagawa, A Uchida, E M Kokoschka, et al.Pageof 650